• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·MEGA-R.BK
Share

Mega Lifesciences Public Company Limited Stocks

THB 34Last Updated 12.06.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

THB 912.61M

THB 34
Key Takeaways

Risk factor

Limited trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, was founded in 1982 and is based in Bangkok, Thailand. This diversified healthcare enterprise is primarily involved in the production, promotion, and sale of an extensive array of health-related products, encompassing dietary supplements, over-the-counter (OTC) and prescription pharmaceuticals, herbal remedies, vitamins, and fast-moving consumer goods. The company organizes its activities across three main divisions: Brands, Distribution, and Original Equipment Manufacture (OEM). Its vast product portfolio includes a wide selection of complementary medicines designed for various needs, such as bone and joint support, children's health, diabetes and heart care, herbal solutions, liver and digestive well-being, skin health, weight management, overall vitality, specific men's and women's health products, and sports nutrition. Additionally, the pharmaceutical segment provides OTC solutions for gastrointestinal issues and pain, alongside a comprehensive range of prescription drugs targeting therapeutic areas like iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain management, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its core product lines, Mega Lifesciences offers logistical and marketing services for goods manufactured by other companies. It also operates wellness centers and engages in software design, development, and related service provisions. The company maintains a strong global footprint, with operations spanning the Asia Pacific, the Middle East, Africa, and the Commonwealth of Independent States regions.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 22:31

U.S. and Iran to sign agreement on June 14, Strait of Hormuz to reopen - Trump

13.06.2026 16:01

Small caps last week: Record biotech IPO, Wizz Air's solid top line, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026